SCHEMBL31455292

SCHEMBL31455292

CC(C)(C)OC(=O)Nc1ccc(Nc2nc(-c3ccc(F)cc3)ccc2[N+](=O)[O-])cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MCL1 Q07820 1/20 0.38
PTK2B Q14289 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
ALOX12 P18054 1/20 0.38
SCN9A Q15858 3/20 0.38
BRD4 O60885 1/20 0.37
AR P10275 3/20 0.37
GSK3B P49841 1/20 0.36
DYRK1A Q13627 1/20 0.36
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455818 1.00 PRMT1 (0.41) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31420343 0.92 PRMT1 (0.41) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455251 0.88 PRMT1 (0.43) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455428 0.85 FGFR4 (0.44) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455563 0.84 PRMT1 (0.43) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455392 0.83 PORCN (0.41) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455040 0.82 PRMT1 (0.40) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455801 0.82 NPC1 (0.46) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL31454993 0.82 PRMT1 (0.40) PRMT1MEN1KMT2ACYP1A2CYP3A4
SCHEMBL31455002 0.80 PRMT1 (0.49) PRMT1MEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed